Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer

This publication has 17 references indexed in Scilit:

• RE: TIME TO NORMALIZATION OF SERUM TESTOSTERONE AFTER 3-MONTH LUTEINIZING HORMONE-RELEASING HORMONE AGONIST ADMINISTERED IN THE NEOADJUVANT SETTING
  Journal of Urology, 1999
• Intermittent androgen suppression in the management of prostate cancer
  Urology, 1999
• TIME TO NORMALIZATION OF SERUM TESTOSTERONE AFTER 3-MONTH LUTEINIZING HORMONE-RELEASING HORMONE AGONIST ADMINISTERED IN THE NEOADJUVANT SETTING: IMPLICATIONS FOR DOSING SCHEDULE AND NEOADJUVANT STUDY CONSIDERATION
  Journal of Urology, 1998
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer
  Urology, 1996
• The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
  Urology, 1995
• Neoadjuvant Hormonal Downsizing of Localized Carcinoma of the Prostate: Effects on the Volume of Normal Tissue Irradiation
  Cancer Investigation, 1995
• Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1994
• The Effects of External Beam Radiotherapy on Endocrine Function in Patients with Carcinoma of the Prostate
  Journal of Urology, 1986